Biotech, Finally - It has been 30 years of promising research and crushing commercial disappointments. Now a burst of breakthroughs may be the tipping point for biotech. Some 230 biotech-based medicines and treatments, designed to combat everything from cancer to depression, have come to market. With those tangible products before them, traditional drugmakers are keen to get back in the game. But ...
|Year of Publication:||
|Type of Publication:||Article|
|Title record from database:|| OLC-SSG Economic Sciences|
|Availability:||More access options|
|More options (other):|
|Description not available.|